Prasugrel 5 mg, clopidogrel similarly safe, effective in non-PCI elderly with ACS

Cutting its dosage in half for patients aged >75 lowered prasugrel's bleeding risk to clopidogrel's risk level while providing comparable clinical benefit in the TRILOGY ACS trial; concerns were that a full prasugrel dosage in the elderly would pose too much of a bleeding risk.
Source: theHeart.org - Category: Cardiology Source Type: news